Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis
- PMID: 22385962
- PMCID: PMC3707508
- DOI: 10.1016/j.cell.2011.12.034
Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis
Abstract
Lamellipodia are sheet-like, leading edge protrusions in firmly adherent cells that contain Arp2/3-generated dendritic actin networks. Although lamellipodia are widely believed to be critical for directional cell motility, this notion has not been rigorously tested. Using fibroblasts derived from Ink4a/Arf-deficient mice, we generated a stable line depleted of Arp2/3 complex that lacks lamellipodia. This line shows defective random cell motility and relies on a filopodia-based protrusion system. Utilizing a microfluidic gradient generation system, we tested the role of Arp2/3 complex and lamellipodia in directional cell migration. Surprisingly, Arp2/3-depleted cells respond normally to shallow gradients of PDGF, indicating that lamellipodia are not required for fibroblast chemotaxis. Conversely, these cells cannot respond to a surface-bound gradient of extracellular matrix (haptotaxis). Consistent with this finding, cells depleted of Arp2/3 fail to globally align focal adhesions, suggesting that one principle function of lamellipodia is to organize cell-matrix adhesions in a spatially coherent manner.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures







References
-
- Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during affinity maturation. Science. 2007;315:528–531. - PubMed
-
- Arrieumerlou C, Meyer T. A local coupling model and compass parameter for eukaryotic chemotaxis. Developmental cell. 2005;8:215–227. - PubMed
-
- Bear JE, Svitkina TM, Krause M, Schafer DA, Loureiro JJ, Strasser GA, Maly IV, Chaga OY, Cooper JA, Borisy GG, et al. Antagonism between Ena/VASP Proteins and Actin Filament Capping Regulates Fibroblast Motility. Cell. 2002;109:509–521. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DK037871/DK/NIDDK NIH HHS/United States
- R01 GM083035/GM/NIGMS NIH HHS/United States
- U01-CA141576/CA/NCI NIH HHS/United States
- R01 ES013773/ES/NIEHS NIH HHS/United States
- R01 CA163896/CA/NCI NIH HHS/United States
- R01 GM031819/GM/NIGMS NIH HHS/United States
- R01 AG024379/AG/NIA NIH HHS/United States
- CA16086/CA/NCI NIH HHS/United States
- R01 DK037871/DK/NIDDK NIH HHS/United States
- GM083035/GM/NIGMS NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- P30 CA016086/CA/NCI NIH HHS/United States
- GM31819/GM/NIGMS NIH HHS/United States
- R56 ES013773/ES/NIEHS NIH HHS/United States
- U01 CA141576/CA/NCI NIH HHS/United States
- ES 13773/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources